Back
bluebird bio Vs. Perspective Therapeutics Industry Stock Comparison
Sell
24
BLUE
bluebird bio
Last Price:
0.41
Seasonality Move:
6.96%
Sell
30
CATX
Perspective Therapeutics
Last Price:
11.25
Seasonality Move:
28.97%
Sell
24
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy, Sell or Hold?
- The current bluebird bio [BLUE] share price is $0.41. The Score for BLUE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $11.25. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLUE Stock Price Chart
What is bluebird bio's stock price today?
-
The bluebird bio share price today is $0.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $11.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
BLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 32.91 | Sell |
Chaikin Money Flow: | 1891067 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.52) | Sell |
Bollinger Bands (100): | (0.47 - 1.01) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.34 | Sell |
Relative Strength Index (14 RSI): | 37.67 | Sell |
Chaikin Money Flow: | -398509 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.74 - 12.94) | Sell |
Bollinger Bands (100): | (11.27 - 14.33) | Sell |
BLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.45 | Sell |
20-day SMA: | 0.48 | Sell |
50-day SMA: | 0.51 | Sell |
200-day SMA: | 0.93 | Sell |
8-day EMA: | 0.44 | Sell |
20-day EMA: | 0.47 | Sell |
50-day EMA: | 0.55 | Sell |
200-day EMA: | 1.14 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.91 | Sell |
20-day SMA: | 12.12 | Sell |
50-day SMA: | 13.16 | Sell |
200-day SMA: | 12.73 | Sell |
8-day EMA: | 11.88 | Sell |
20-day EMA: | 12.17 | Sell |
50-day EMA: | 12.7 | Sell |
200-day EMA: | 11.77 | Sell |
bluebird bio Earnings Growth & BLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.46 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
bluebird bio Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |